Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabio Nicolini
Observed names:
F. Nicolini,
Fabio NICOLINI,
Nicolini, Fabio
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Universidad de Las Palmas de Gran Canaria,
Consejo Superior de Investigaciones Científicas,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Canary Institute of Cancer Research,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-6846-5435
Observed ORCID:
0000-0001-6846-5435
OpenAlex ID:
A5041172440
Works
49
Awards
2
A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
2025
·
Sean Nolan
, Marissa Vignali
, et al.
·
Frontiers in Immunology
·
241
PDF
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
2025
·
Thomas M. Snyder
, Rachel M. Gittelman
, et al.
·
Frontiers in Immunology
·
226
PDF
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
2020
·
Fabio Nicolini
, Martine Bocchini
, et al.
·
Frontiers in Oncology
·
88
PDF
Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells
2013
·
Fabio Nicolini
, Olga Burmistrova
, et al.
·
Molecular Carcinogenesis
·
56
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
2020
·
Martine Bocchini
, Fabio Nicolini
, et al.
·
Frontiers in Oncology
·
55
PDF
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
2020
·
Sara Ravaioli
, Michela Tebaldi
, et al.
·
Cell Transplantation
·
43
PDF
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
2021
·
Massimo Martino
, Filippo Antonio Canale
, et al.
·
Cancers
·
41
PDF
Polycomb RING1A/RING1B-dependent histone H2A monoubiquitylation at pericentromeric regions promotes S phase progression
2015
·
Mónica Bravo
, Fabio Nicolini
, et al.
·
Journal of Cell Science
·
32
PDF
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
2025
·
Anna De Lucia
, Lucia Mazzotti
, et al.
·
Frontiers in Immunology
·
30
PDF
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia
2022
·
Sarah Tettamanti
, Maria Caterina Rotiroti
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
27
Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19
2021
·
Sara Bravaccini
, Eugenio Fonzi
, et al.
·
Cell Transplantation
·
24
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon
2022
·
Massimo Martino
, Virginia Naso
, et al.
·
International Journal of Molecular Sciences
·
19
PDF
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream
2024
·
Luana Calabrò
, Giuseppe Bronte
, et al.
·
Frontiers in Immunology
·
18
PDF
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design
2024
·
Anna Gaimari
, Anna De Lucia
, et al.
·
International Journal of Molecular Sciences
·
16
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors
2023
·
Martine Bocchini
, Marcella Tazzari
, et al.
·
Frontiers in Oncology
·
9
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
2021
·
Fabio Nicolini
, Martine Bocchini
, et al.
·
Vide Leaf, Hyderabad eBooks
·
8
PDF
First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19
2025
·
Sara Bravaccini
, Fabio Nicolini
, et al.
·
Scientific Reports
·
7
PDF
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy
2024
·
Roberta Maltoni
, Andrea Roncadori
, et al.
·
Biomedicines
·
7
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic
2023
·
Filippo A. Canale
, Massimo Martino
, et al.
·
Supportive Care in Cancer
·
6
PDF
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS ‐ CoV ‐2 in Exposed Individuals From Emilia Romagna Region and COVID ‐19 Severity
2025
·
Lucia Mazzotti
, Patricia Borges de Souza
, et al.
·
HLA
·
5
PDF
CAR T cells targeting options in the fight against multiple myeloma
2021
·
Fabio NICOLINI
, Sara BRAVACCINI
, et al.
·
Panminerva Medica
·
5
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability
2025
·
Ilaria Pisani
, Giusi Melita
, et al.
·
Journal of Translational Medicine
·
3
PDF
Why the complications of COVID-19 patients differ in elderly and young cancer patients
2022
·
Sara Bravaccini
, Fabio Nicolini
, et al.
·
Translational Oncology
·
3
PDF
Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting
2020
·
Fabio Nicolini
, Martine Bocchini
, et al.
·
Cancers
·
3
PDF
Special Issue “The Promising Future of CAR-Based Therapies: A Matter of Molecular Details”
2025
·
Fabio Nicolini
, Orsola Montini
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Show more works
View as search
Works count:
49
Citation count:
979
H-index:
14
I10-index:
14
Year
Topic
Type